buspirone has been researched along with Claustrophobia in 20 studies
Buspirone: An anxiolytic agent and serotonin receptor agonist belonging to the azaspirodecanedione class of compounds. Its structure is unrelated to those of the BENZODIAZAPINES, but it has an efficacy comparable to DIAZEPAM.
buspirone : An azaspiro compound that is 8-azaspiro[4.5]decane-7,9-dione substituted at the nitrogen atom by a 4-(piperazin-1-yl)butyl group which in turn is substituted by a pyrimidin-2-yl group at the N(4) position.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The novel anxiolytic agent buspirone has been shown to be effective in generalized anxiety disorder, but its utility in phobic disorders is less clear." | 5.07 | Buspirone in social phobia. ( Campeas, R; Coplan, J; Fallon, BA; Hollander, E; Liebowitz, MR; Saoud, JB; Schneier, FR, 1993) |
| "A case report involving buspirone hydrochloride in the successful treatment of a patient with an atypical paraphilia and transvestic fetishism is presented." | 3.68 | Buspirone hydrochloride in the treatment of an atypical paraphilia. ( Fedoroff, JP, 1992) |
| "Four patients with panic disorder whose panic attacks responded to benzodiazepine treatment but who suffered persistent anxiety improved after addition of buspirone." | 3.67 | Adjunctive buspirone in benzodiazepine treatment of four patients with panic disorder. ( Gastfriend, DR; Rosenbaum, JF, 1989) |
| "Buspirone, which is a partial agonist at 5HT1A receptors, increases prolactin release and may be used as a probe to examine serotonergic responses, dysfunction of which may be relevant to the pathophysiology of social phobia." | 2.70 | A preliminary study of buspirone stimulated prolactin release in generalised social phobia: evidence for enhanced serotonergic responsivity? ( Condren, RM; Dinan, TG; Thakore, JH, 2002) |
| "Buspirone was compared with imipramine and placebo in the treatment of panic disorder in an 8-week, double-blind controlled study of 52 randomly assigned patients." | 2.67 | Is buspirone effective for panic disorder? ( Raj, AB; Sheehan, DV; Sheehan, KH; Soto, S, 1990) |
| "Anxiety disorders are chronic illnesses requiring long-term treatment." | 2.38 | Chronic anxiety: deciding the length of treatment. ( Gorman, JM; Papp, LA, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (25.00) | 18.7374 |
| 1990's | 10 (50.00) | 18.2507 |
| 2000's | 2 (10.00) | 29.6817 |
| 2010's | 3 (15.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dzampaev, AT | 1 |
| Suvorova, IA | 1 |
| Damulin, IV | 1 |
| Levin, OS | 1 |
| Ravindran, LN | 1 |
| Stein, MB | 1 |
| Condren, RM | 1 |
| Dinan, TG | 1 |
| Thakore, JH | 1 |
| Leveleki, C | 1 |
| Sziray, N | 1 |
| Levay, G | 1 |
| Barsvári, B | 1 |
| Soproni, K | 1 |
| Mikics, E | 1 |
| Haller, J | 1 |
| Altesman, RI | 1 |
| Cole, JO | 1 |
| Zwier, KJ | 1 |
| Rao, U | 1 |
| Liebowitz, MR | 3 |
| Schneier, FR | 2 |
| Saoud, JB | 2 |
| Campeas, R | 2 |
| Fallon, BA | 2 |
| Hollander, E | 2 |
| Coplan, J | 1 |
| Van Ameringen, M | 1 |
| Mancini, C | 1 |
| Wilson, C | 1 |
| van Vliet, IM | 1 |
| den Boer, JA | 1 |
| Westenberg, HG | 1 |
| Pian, KL | 1 |
| Tancer, ME | 1 |
| Uhde, TW | 1 |
| Fedoroff, JP | 1 |
| Welkowitz, LA | 1 |
| Feerick, J | 1 |
| Street, L | 1 |
| Gitow, A | 1 |
| Gorman, JM | 1 |
| Papp, LA | 1 |
| Sheehan, DV | 1 |
| Raj, AB | 1 |
| Sheehan, KH | 1 |
| Soto, S | 1 |
| Gastfriend, DR | 1 |
| Rosenbaum, JF | 1 |
| Pohl, R | 1 |
| Balon, R | 1 |
| Yeragani, VK | 1 |
| Gershon, S | 1 |
| Teicher, MH | 1 |
| Hoehn-Saric, R | 1 |
| McLeod, DR | 1 |
6 reviews available for buspirone and Claustrophobia
| Article | Year |
|---|---|
[Clinical potential and possibilities of using buspirone in the treatment of anxiety disorders].
Topics: Anti-Anxiety Agents; Anxiety Disorders; Buspirone; Comorbidity; Humans; Panic Disorder; Phobic Disor | 2014 |
The pharmacologic treatment of anxiety disorders: a review of progress.
Topics: Anticonvulsants; Antidepressive Agents; Antipsychotic Agents; Anxiety Disorders; Benzodiazepines; Bu | 2010 |
Role of serotonin drugs in the treatment of social phobia.
Topics: Buspirone; Clinical Trials as Topic; Double-Blind Method; Fluvoxamine; Humans; Ondansetron; Phobic D | 1997 |
Chronic anxiety: deciding the length of treatment.
Topics: Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Buspirone; Chronic Disease; Drug Administra | 1990 |
Biology of anxiety.
Topics: Agoraphobia; Anxiety Disorders; Buspirone; Fear; Humans; Panic; Phobic Disorders; Receptors, GABA-A | 1988 |
Generalized anxiety disorder.
Topics: Adrenergic beta-Antagonists; Alprazolam; Animals; Anti-Anxiety Agents; Antidepressive Agents, Tricyc | 1985 |
5 trials available for buspirone and Claustrophobia
| Article | Year |
|---|---|
A preliminary study of buspirone stimulated prolactin release in generalised social phobia: evidence for enhanced serotonergic responsivity?
Topics: Adult; Area Under Curve; Buspirone; Female; Humans; Male; Middle Aged; Phobic Disorders; Prolactin; | 2002 |
Buspirone in social phobia.
Topics: Adult; Buspirone; Female; Humans; Male; Middle Aged; Phobic Disorders; Psychiatric Status Rating Sca | 1993 |
Clinical effects of buspirone in social phobia: a double-blind placebo-controlled study.
Topics: Buspirone; Double-Blind Method; Drug Administration Schedule; Humans; Phobic Disorders; Placebos; Tr | 1997 |
Is buspirone effective for panic disorder?
Topics: Adult; Agoraphobia; Anxiety Disorders; Arousal; Buspirone; Double-Blind Method; Fear; Female; Follow | 1990 |
Serotonergic anxiolytics in the treatment of panic disorder: a controlled study with buspirone.
Topics: Adult; Agoraphobia; Brain; Buspirone; Clinical Trials as Topic; Double-Blind Method; Fear; Female; H | 1989 |
9 other studies available for buspirone and Claustrophobia
| Article | Year |
|---|---|
[The use of buspirone in clinical practice].
Topics: Anti-Anxiety Agents; Anxiety; Buspirone; Depression; Dyskinesia, Drug-Induced; Humans; Parkinson Dis | 2015 |
Pharmacological evaluation of the stress-induced social avoidance model of anxiety.
Topics: Animals; Anti-Anxiety Agents; Anxiety Disorders; Brain; Buspirone; Chlordiazepoxide; Diazepam; Disea | 2006 |
Psychopharmacologic treatment of anxiety.
Topics: Adrenergic beta-Antagonists; Anti-Anxiety Agents; Antipsychotic Agents; Anxiety Disorders; Benzodiaz | 1983 |
Buspirone use in an adolescent with social phobia and mixed personality disorder (cluster A type).
Topics: Adolescent; Buspirone; Combined Modality Therapy; Follow-Up Studies; Hospitalization; Hospitals, Psy | 1994 |
Pharmacotherapy of social phobia.
Topics: Adult; Antidepressive Agents, Tricyclic; Benzodiazepines; Buspirone; Clinical Trials as Topic; Doubl | 1993 |
Buspirone augmentation of selective serotonin reuptake inhibitors (SSRIs) in social phobia.
Topics: Adolescent; Adult; Anti-Anxiety Agents; Buspirone; Dose-Response Relationship, Drug; Drug Administra | 1996 |
Buspirone hydrochloride in the treatment of an atypical paraphilia.
Topics: Adult; Buspirone; Dose-Response Relationship, Drug; Fantasy; Fetishism, Psychiatric; Humans; Incest; | 1992 |
Treatment of social phobia with drugs other than benzodiazepines.
Topics: Adolescent; Atenolol; Benzamides; Buspirone; Child; Clinical Trials as Topic; Female; Fluoxetine; Hu | 1991 |
Adjunctive buspirone in benzodiazepine treatment of four patients with panic disorder.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anxiety; Buspirone; Clonazepam; Diazepam; Drug Combinations; | 1989 |